Thank you, Michael. On page 4, we present the company's key metrics for the second quarter of 2019. Net income was $12.2 million, an increase of $11.3 million over the prior-year period. The increase was primarily driven by two factors, continued growth in insurance underwriting operations and $12.4 million of pre-tax gains on investments versus $3.8 million of mark-to-market losses in the second quarter of 2018. Included in the pre-tax gain on investments is a $7.6 million gain recorded on the sale of our Telos CLO asset management business in the second quarter. Net income for the year-to-date period was $16.5 million, down significantly given the prior-year gain on sale of our senior living operations. Excluding that gain and income from discontinued operations, net income before non-controlling interest was up $21.1 million. The primary drivers of this increase can be attributed to similar factors as the quarter. Operating EBITDA for the quarter was $12.7 million, down from the prior year due primarily to the repositioning of our investment portfolio and the resulting buildup of cash still to be deployed. Operating EBITDA for the year-to-date period was $25.3 million, up 5.9% from the prior-year period. While both periods were impacted by the realignment of the insurance investment portfolio, the year-to-date results were more than offset by insurance underwriting growth and contributions from shipping operations. On the bottom of the page, we show a walk from operating EBITDA to total pre-tax income, highlighting the key differences between the two metrics. Book value per share increased to $11.47, up $0.68 from year-end 2018, driven by improved earnings in addition to share buybacks over the past four quarters at an average 40% discount to book. Turning to page 5, we highlight our capital allocated between insurance and Tiptree Capital, along with the respective returns to assist investors in understanding Tiptree's enterprise value. When considering capital allocation decisions, we look at total capital, which includes corporate debt held at both the holding company and our insurance subsidiary. We valuate our return on capital using trailing 12-month operating EBITDA, which for the most recent period was $56.3 million. Our total return of approximately 8.4% is composed of 13.9% return in specialty insurance and an 8.6% return in Tiptree Capital. The key drivers of our returns for the period were growth in insurance operating EBITDA across all product lines, consistent and stable dividends from our Invesque shares, positive contributions from shipping operations in Tiptree Capital and relatively stable corporate expenses. Now, let's turn to our specialty insurance results. On page 7, we highlight our underwriting performance and then on the following page returns from the investment portfolio. We continue to see positive top line growth across our product lines, including our European warranty program. For the first half of 2019, gross written premiums grew $67 million year-over-year, up 17%, and net written premiums grew 34%. We believe that there are number of fundamental factors which provide support to continue this growth moving forward. Within warranty, our opportunities exist partly because of the size and growth trajectory of the overall market. We have made great strides penetrating this sector and believe it has a long runway for growth. Second, the nature of the claims we incur in our product lines do not change substantially through different economic cycles. And typically, consumers keep their cars and appliances longer in a slowing economy, which we believe may increase demand for extended service contracts. Underwriting margin was up 11% and our combined ratio held steady at 93.2%, demonstrating our ability to continue to grow profitably in our insurance business. This quarter, I would also like to highlight that we have built a substantial balance of $726 million of unearned premiums and deferred revenues on our balance sheet, up 23% from this time last year. This growth is key to our future earnings, both from underwriting profits as well as contributions from the growing investment portfolio of paid-in premium. Turning to the investment portfolio on page 8, our net investments grew by $79 million year-over-year, up 19%, driven by our growth in net written premiums. Year-to-date, net investment income was $7.7 million, down $1.4 million as we reduced our exposure to corporate loans, thus decreasing our interest income. We ended the quarter with $124 million of cash in the insurance portfolio, which is available for investments. Net portfolio income was $12.9 million, up approximately $8.2 million versus the prior year. The improved performance was driven by 2019 unrealized gains versus losses in the prior-year period, combined with lower asset-based interest expense. On page 10, we present the results of Tiptree Capital, which primarily consists of our Invesque shares and shipping operations. Over time, we would expect that our investments could shift as we recognize returns in one asset class or business and reinvest in others. Our senior living results are included in our 2018 results to facilitate period-over-period comparison. As of the end of the second quarter, our Invesque division represents a $119 million, of which $99 million is held in Tiptree Capital. The remainder is in our insurance portfolio. The final transfer restrictions on our Invesque shares expired on August 1, 2019. The remaining discount will accrete into income over the third quarter. Year-to-date, real asset operating EBITDA was $6.8 million, which includes dividends on our Invesque shares and the results from our shipping operations. Specialty finance operating EBITDA was stable, while pre-tax income declined due to a $1.6 million mark-to-market loss on our MSR portfolio as mortgage interest rates declined. Now, we will turn the call back to Michael to conclude our prepared remarks.